Abstract
AimsESD is an established therapeutic option for the management of early Barrett’s neoplasia, offering superior en-bloc and R0 resection rates compared to endoscopic mucosal resection. However, ESD is thought to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
